{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:06:25Z","timestamp":1791515185974,"version":"4.3.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03846-5","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T06:36:57Z","timestamp":1763620617000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Surface-engineered hyaluronic acid-coated lyotropic liquid crystalline nanoparticles for CD44-targeting of 3-Acetyl-11-keto-\u03b2-boswellic acid in rheumatoid arthritis treatment"],"prefix":"10.1186","volume":"23","author":[{"given":"Sakshi","family":"Priya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vagesh","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniruddha","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Singhvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"3846_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmed.2025.1526218","volume":"12","author":"W Shi","year":"2025","unstructured":"Shi W, Liang X, Zhang H, Li H. Burden of rheumatoid arthritis in India from 1990 to 2021: insights from the global burden of disease database. Front Med. 2025;12:1\u20139. https:\/\/doi.org\/10.3389\/fmed.2025.1526218.","journal-title":"Front Med"},{"key":"3846_CR2","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00296-020-04731-0","volume":"41","author":"K Almutairi","year":"2021","unstructured":"Almutairi K, Nossent J, Preen D, Keen H, Inderjeeth C. The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review. Rheumatol Int. 2021;41:863\u201377. https:\/\/doi.org\/10.1007\/s00296-020-04731-0.","journal-title":"Rheumatol Int"},{"key":"3846_CR3","doi-asserted-by":"publisher","DOI":"10.1039\/d4nr03611e","author":"S Priya","year":"2024","unstructured":"Priya S, Jain KK, Daryani J, Desai VM, Kathuria H, Singhvi G. Revolutionizing rheumatoid arthritis treatment with emerging cutaneous drug delivery systems: overcoming the challenges and paving the way forward. Nanoscale. 2024. https:\/\/doi.org\/10.1039\/d4nr03611e.","journal-title":"Nanoscale"},{"key":"3846_CR4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.31138\/mjr.28.4.223","volume":"28","author":"AI Venetsanopoulou","year":"2017","unstructured":"Venetsanopoulou AI, Alamanos Y, Voulgari PV, Drosos AA. Epidemiology and risk factors for rheumatoid arthritis development. Mediterr J Rheumatol. 2017;28:223\u20136.","journal-title":"Mediterr J Rheumatol"},{"key":"3846_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmed.2022.1049875","volume":"9","author":"R Watanabe","year":"2022","unstructured":"Watanabe R, Okano T, Gon T, Yoshida N, Fukumoto K, Yamada S, Hashimoto M. Difficult-to-treat rheumatoid arthritis: current concept and unsolved problems. Front Med. 2022;9:1\u20137. https:\/\/doi.org\/10.3389\/fmed.2022.1049875.","journal-title":"Front Med"},{"key":"3846_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2022.945129","volume":"13","author":"X Liu","year":"2022","unstructured":"Liu X, Wang Z, Qian H, Tao W, Zhang Y, Hu C, Mao W, Guo Q. Natural medicines of targeted rheumatoid arthritis and its action mechanism. Front Immunol. 2022;13:1\u201319. https:\/\/doi.org\/10.3389\/fimmu.2022.945129.","journal-title":"Front Immunol"},{"key":"3846_CR7","doi-asserted-by":"publisher","unstructured":"Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Neurol 4 JAN. 2014;1\u201310. https:\/\/doi.org\/10.3389\/fphar.2013.00177.","DOI":"10.3389\/fphar.2013.00177"},{"key":"3846_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13543784.2023.2269838","volume":"00","author":"S Priya","year":"2023","unstructured":"Priya S, Singhvi G. Insights into the anti-inflammatory and anti-arthritic potential of 3-Acetyl-11-keto-\u03b2-Boswellic acid as a therapeutic approach in rheumatoid Arthritis, expert Opin. Investig Drugs. 2023;00:1\u20135. https:\/\/doi.org\/10.1080\/13543784.2023.2269838.","journal-title":"Investig Drugs"},{"key":"3846_CR9","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.apjtb.2017.05.001","volume":"7","author":"F Iram","year":"2017","unstructured":"Iram F, Khan SA, Husain A. Phytochemistry and potential therapeutic actions of Boswellic acids: a mini-review. Asian Pac J Trop Biomed. 2017;7:513\u201323. https:\/\/doi.org\/10.1016\/j.apjtb.2017.05.001.","journal-title":"Asian Pac J Trop Biomed"},{"key":"3846_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.hermed.2016.08.002","volume":"6","author":"PR Vuddanda","year":"2016","unstructured":"Vuddanda PR, Singh S, Velaga S. Boswellic acid \u2013 medicinal use of an ancient herbal remedy. J Herbal Med. 2016;6:163\u201370. https:\/\/doi.org\/10.1016\/j.hermed.2016.08.002.","journal-title":"J Herbal Med"},{"key":"3846_CR11","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.3109\/10717544.2016.1149744","volume":"23","author":"M Mehta","year":"2016","unstructured":"Mehta M, Dureja H, Garg M. Development and optimization of Boswellic acid-loaded proniosomal gel. Drug Deliv. 2016;23:3072\u201381. https:\/\/doi.org\/10.3109\/10717544.2016.1149744.","journal-title":"Drug Deliv"},{"key":"3846_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/nano8010042","author":"SY Chuang","year":"2018","unstructured":"Chuang SY, Lin CH, Huang TH, Fang JY. Lipid-based nanoparticles as a potential delivery approach in the treatment of rheumatoid arthritis. Nanomaterials. 2018. https:\/\/doi.org\/10.3390\/nano8010042.","journal-title":"Nanomaterials"},{"key":"3846_CR13","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1111\/jphp.12420","volume":"67","author":"K Bairwa","year":"2015","unstructured":"Bairwa K, Jachak SM. Development and optimisation of 3-acetyl-11-keto-\u03b2-boswellic acid loaded poly-lactic-co-glycolic acid-nanoparticles with enhanced oral bioavailability and in-vivo anti-inflammatory activity in rats. J Pharm Pharmacol. 2015;67:1188\u201397. https:\/\/doi.org\/10.1111\/jphp.12420.","journal-title":"J Pharm Pharmacol"},{"issue":"2","key":"3846_CR14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1211\/jpp.62.02.0016","volume":"62","author":"A Goel","year":"2010","unstructured":"Goel A, Ahmad FJ, Singh RM, Singh GN. 3-acetyl-11-keto-\u03b2-boswellic acid loaded-polymeric nanomicelles for topical anti-inflammatory and anti-arthritic activity. J Pharm Pharmacol. 2010;62(2):273\u20138. https:\/\/doi.org\/10.1211\/jpp.62.02.0016.","journal-title":"J Pharm Pharmacol"},{"key":"3846_CR15","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.2147\/DDDT.S265167","volume":"14","author":"F Badria","year":"2020","unstructured":"Badria F, Mazyed E. Formulation of nanospanlastics as a promising approach for improving the topical delivery of a natural leukotriene inhibitor (3-acetyl-11-keto-\u03b2-boswellic acid): statistical optimization, in vitro characterization, and ex vivo permeation study. Drug Des Devel Ther. 2020;14:3697\u2013721. https:\/\/doi.org\/10.2147\/DDDT.S265167.","journal-title":"Drug Des Devel Ther"},{"key":"3846_CR16","doi-asserted-by":"publisher","first-page":"10688","DOI":"10.1021\/la301579g","volume":"28","author":"DP Chang","year":"2012","unstructured":"Chang DP, Jankunec M, Barauskas J, Tiberg F, Nylander T. Adsorption of lipid liquid crystalline nanoparticles: effects of particle composition, internal structure, and phase behavior. Langmuir. 2012;28:10688\u201396. https:\/\/doi.org\/10.1021\/la301579g.","journal-title":"Langmuir"},{"key":"3846_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.121939","volume":"623","author":"M Zewail","year":"2022","unstructured":"Zewail M, EL-Deeb NM, Mousa MR, Abbas H. Hyaluronic acid coated Teriflunomide (A771726) loaded lipid carriers for the oral management of rheumatoid arthritis. Int J Pharm. 2022;623:121939. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.121939.","journal-title":"Int J Pharm"},{"key":"3846_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.132586","volume":"271","author":"S Priya","year":"2024","unstructured":"Priya S, Daryani J, Desai VM, Singhvi G. Bridging the gap in rheumatoid arthritis treatment with hyaluronic acid-based drug delivery approaches. Int J Biol Macromol. 2024;271:132586. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.132586.","journal-title":"Int J Biol Macromol"},{"key":"3846_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ijbiomac.2022.10.117","volume":"224","author":"S Gorantla","year":"2023","unstructured":"Gorantla S, Puppala ER, Naidu VGM, Saha RN, Singhvi G. Hyaluronic acid-coated proglycosomes for topical delivery of Tofacitinib in rheumatoid arthritis condition: formulation design, in vitro, ex vivo characterization, and in vivo efficacy studies. Int J Biol Macromol. 2023;224:207\u201322. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.10.117.","journal-title":"Int J Biol Macromol"},{"key":"3846_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2021.117053","volume":"346","author":"S Gorantla","year":"2022","unstructured":"Gorantla S, Saha RN, Singhvi G. Exploring the affluent potential of Glyceryl mono oleate \u2013 myristol liquid crystal nanoparticles mediated localized topical delivery of tofacitinib: study of systematic qbd, skin deposition and dermal pharmacokinetics assessment. J Mol Liq. 2022;346:117053. https:\/\/doi.org\/10.1016\/j.molliq.2021.117053.","journal-title":"J Mol Liq"},{"key":"3846_CR21","doi-asserted-by":"publisher","DOI":"10.1063\/5.0204909","author":"S Priya","year":"2024","unstructured":"Priya S, Desai VM, Singhvi G. Tailoring lyotropic liquid crystals for skin barrier penetration: exploring composition and structure\u2013functionrelationships. Appl Phys Rev. 2024. https:\/\/doi.org\/10.1063\/5.0204909.","journal-title":"Appl Phys Rev"},{"key":"3846_CR22","doi-asserted-by":"publisher","first-page":"100137","DOI":"10.1016\/j.carpta.2021.100137","volume":"2","author":"DK Jha","year":"2021","unstructured":"Jha DK, Shah DS, Amin PD. Effect of hypromellose acetate succinate substituents on miscibility behavior of Spray-dried amorphous solid dispersions: Flory\u2013Huggins parameter prediction and Validation, carbohydr. Polym Technol Appl. 2021;2:100137. https:\/\/doi.org\/10.1016\/j.carpta.2021.100137.","journal-title":"Polym Technol Appl"},{"key":"3846_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-27665-6","volume":"13","author":"KY Mahmoud","year":"2023","unstructured":"Mahmoud KY, Elhesaisy NA, Rashed AR, Mikhael ES, Fadl MI, Elsadek MS, Mohamed MA, Mostafa MA, Hassan MA, Halema OM, Elnemer YH, Swidan SA. Exploring the potential of intranasally administered naturally occurring Quercetin loaded into polymeric nanocapsules as a novel platform for the treatment of anxiety. Sci Rep. 2023;13:1\u201314. https:\/\/doi.org\/10.1038\/s41598-023-27665-6.","journal-title":"Sci Rep"},{"key":"3846_CR24","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s12088-024-01338-y","volume":"65","author":"M Tekade","year":"2025","unstructured":"Tekade M, Sharma MC. Quality-by-design (QbD) assisted synthesis of nanoparticle for efficient loading, stabilization, and intracellular delivery of bioactive for the treatment of arthritis. Indian J Microbiol. 2025;65:477\u2013504. https:\/\/doi.org\/10.1007\/s12088-024-01338-y.","journal-title":"Indian J Microbiol"},{"key":"3846_CR25","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.1039\/d4ay00814f","volume":"16","author":"S Priya","year":"2024","unstructured":"Priya S, Singhvi G. Determination of 3-acetyl-11-keto-\u03b2-boswellic acid in analytical and biological samples using streamlined and robust RP-HPLC method. Anal Methods. 2024;16:3847\u201358. https:\/\/doi.org\/10.1039\/d4ay00814f.","journal-title":"Anal Methods"},{"key":"3846_CR26","doi-asserted-by":"publisher","first-page":"853","DOI":"10.2147\/IJN.S97000","volume":"11","author":"DR Lee","year":"2016","unstructured":"Lee DR, Park JS, Bae IH, Lee Y, Kim BM. Liquid crystal nanoparticle formulation as an oral drug delivery system for liver-specific distribution. Int J Nanomed. 2016;11:853\u201371. https:\/\/doi.org\/10.2147\/IJN.S97000.","journal-title":"Int J Nanomed"},{"key":"3846_CR27","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejpb.2023.03.004","volume":"186","author":"T Waghule","year":"2023","unstructured":"Waghule T, Laxmi Swetha K, Roy A, Narayan Saha R, Singhvi G. Exploring Temozolomide encapsulated pegylated liposomes and lyotropic liquid crystals for effective treatment of glioblastoma: in-vitro, cell line, and Pharmacokinetic studies. Eur J Pharm Biopharm. 2023;186:18\u201329. https:\/\/doi.org\/10.1016\/j.ejpb.2023.03.004.","journal-title":"Eur J Pharm Biopharm"},{"key":"3846_CR28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jconrel.2021.11.019","volume":"341","author":"H Li","year":"2022","unstructured":"Li H, Feng Y, Zheng X, Jia M, Mei Z, Wang Y, et al. M2-type exosomes nanoparticles for rheumatoid arthritis therapy via macrophage re-polarization. J Control Release. 2022;341:16\u201330. https:\/\/doi.org\/10.1016\/j.jconrel.2021.11.019.","journal-title":"J Control Release"},{"key":"3846_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules25184089","volume":"25","author":"S Baek","year":"2020","unstructured":"Baek S, Park T, Kang M, Park D. Anti-inflammatory activity and ROS regulation. Molecules. 2020;25:1\u201315.","journal-title":"Molecules"},{"key":"3846_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124829","volume":"666","author":"S Karnam","year":"2024","unstructured":"Karnam S, Jindal AB, Paul AT. Quality by design-based optimization of Teriflunomide and Quercetin combinational topical transferosomes for the treatment of rheumatoid arthritis. Int J Pharm. 2024;666:124829. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124829.","journal-title":"Int J Pharm"},{"key":"3846_CR31","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1007\/s00210-023-02810-0","volume":"397","author":"J Li","year":"2024","unstructured":"Li J, Cao J, Chen Q, Liu D, Li R. Investigating the therapeutic potential of Sinomenine in rheumatoid arthritis: anti-inflammatory, antioxidant, and immunomodulatory mechanisms. Naunyn Schmiedebergs Arch Pharmacol. 2024;397:3945\u201358. https:\/\/doi.org\/10.1007\/s00210-023-02810-0.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"3846_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-020-00675-6","volume":"18","author":"F Yan","year":"2020","unstructured":"Yan F, Zhong Z, Wang Y, Feng Y, Mei Z, Li H, Chen X, Cai L, Li C. Exosome-based biomimetic nanoparticles targeted to inflamed joints for enhanced treatment of rheumatoid arthritis. J Nanobiotechnol. 2020;18:1\u201315. https:\/\/doi.org\/10.1186\/s12951-020-00675-6.","journal-title":"J Nanobiotechnol"},{"key":"3846_CR33","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.1007\/s00210-024-03529-2","volume":"398","author":"R Chaudhary","year":"2025","unstructured":"Chaudhary R, Azam MA, Dowand B, Singh A, Rehman M, Agarwal V, et al. Chronic stress-mediated dysregulations in inflammatory, immune and oxidative circuitry impairs the therapeutic response of methotrexate in experimental autoimmune disease models. Naunyn Schmiedebergs Arch Pharmacol. 2025;398:4305\u201334. https:\/\/doi.org\/10.1007\/s00210-024-03529-2.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"3846_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02784-y","author":"Y Li","year":"2024","unstructured":"Li Y, Wang X, Gao Y, Zhang Z, Liu T, Zhang Z, et al. Hyaluronic acid-coated polypeptide nanogel enhances specific distribution and therapy of tacrolimus in rheumatoid arthritis. J Nanobiotechnol. 2024. https:\/\/doi.org\/10.1186\/s12951-024-02784-y.","journal-title":"J Nanobiotechnol"},{"key":"3846_CR35","doi-asserted-by":"publisher","unstructured":"Helmy HS, El-Sahar AE, Sayed RH, Shamma RN, Salama AH, Elbaz EM. Therapeutic effects of lornoxicam-loaded nanomicellar formula in experimental models of rheumatoid arthritis. Int J Nanomed. 2017;12:7015\u201323. https:\/\/doi.org\/10.2147\/IJN.S147738.","DOI":"10.2147\/IJN.S147738"},{"key":"3846_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2023.101261","volume":"7","author":"S Priya","year":"2024","unstructured":"Priya S, Desai VM, Singhvi G. Spectroscopic method to estimate 3-acetyl-11-keto-\u03b2-boswellic acid in complex lipid nanocarriers and skin matrices. Results Chem. 2024;7:101261. https:\/\/doi.org\/10.1016\/j.rechem.2023.101261.","journal-title":"Results Chem"},{"key":"3846_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.105810","volume":"98","author":"R Kashikar","year":"2024","unstructured":"Kashikar R, Kotha AK, Shrestha R, Channappanavar R, Chougule MB. Design of experiments using box Behnken design in the development, characterization, mathematical modeling, and evaluation of lung targeted nebulized antiviral camostat mesylate loaded pegylated nanosuspension product. J Drug Deliv Sci Technol. 2024;98:105810. https:\/\/doi.org\/10.1016\/j.jddst.2024.105810.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3846_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.105655","volume":"96","author":"A Zafar","year":"2024","unstructured":"Zafar A, Yasir M, Panda DS, Singh L. Bergenin nano-lipid carrier to improve the oral delivery: development, optimization, in vitro and in vivo evaluation. J Drug Deliv Sci Technol. 2024;96:105655. https:\/\/doi.org\/10.1016\/j.jddst.2024.105655.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3846_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114634","volume":"162","author":"VK Rapalli","year":"2023","unstructured":"Rapalli VK, Tomar Y, Sharma S, Roy A, Singhvi G. Apremilast loaded lyotropic liquid crystalline nanoparticles embedded hydrogel for improved permeation and skin retention: an effective approach for psoriasis treatment. Biomed Pharmacother. 2023;162:114634. https:\/\/doi.org\/10.1016\/j.biopha.2023.114634.","journal-title":"Biomed Pharmacother"},{"key":"3846_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-022-28830-7","volume":"13","author":"BC Park","year":"2022","unstructured":"Park BC, Ko MJ, Kim YK, Kim GW, Kim MS, Koo TM, Fu HE, Kim YK. Surface-ligand-induced crystallographic disorder\u2013order transition in oriented attachment for the tuneable assembly of mesocrystals. Nat Commun. 2022;13:1\u201311. https:\/\/doi.org\/10.1038\/s41467-022-28830-7.","journal-title":"Nat Commun"},{"key":"3846_CR41","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1007\/s00018-009-0053-z","volume":"66","author":"H Hillaireau","year":"2009","unstructured":"Hillaireau H, Couvreur P. Nanocarriers\u2019 entry into the cell: relevance to drug delivery. Cell Mol Life Sci. 2009;66:2873\u201396. https:\/\/doi.org\/10.1007\/s00018-009-0053-z.","journal-title":"Cell Mol Life Sci"},{"key":"3846_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2023.156398","volume":"172","author":"R Choudhary","year":"2023","unstructured":"Choudhary R, Saroch D, Kumar D, Anjum S, Andrabi NI, Akram T, et al. Anti-inflammatory and anti-arthritic potential of methotrexate in combination with BA-25, an amino analogue of \u03b2-boswellic acid in the treatment of rheumatoid arthritis. Cytokine. 2023;172:156398. https:\/\/doi.org\/10.1016\/j.cyto.2023.156398.","journal-title":"Cytokine"},{"key":"3846_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.105081","volume":"89","author":"S Priya","year":"2023","unstructured":"Priya S, Srividya G, Chandra NS, Singh PP, Saha RN, Sathe P, et al. Loteprednol etabonate loaded lyotropic liquid crystalline nanoparticles in-situ ophthalmic gel: Qbd driven optimization and in-vitro, ex-vivo evidence of sustained precorneal residence time. J Drug Deliv Sci Technol. 2023;89:105081. https:\/\/doi.org\/10.1016\/j.jddst.2023.105081.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3846_CR44","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1021\/acsabm.4c01743","volume":"8","author":"P Chowdary","year":"2025","unstructured":"Chowdary P, Puppala ER, Putta CL, Maddila JR, Pulavarthy V, Prasad VVSR, et al. Hyaluronic-acid-functionalized tofacitinib loaded transethosomes for targeted drug delivery in rheumatoid arthritis. ACS Appl Bio Mater. 2025;8:1594\u2013606. https:\/\/doi.org\/10.1021\/acsabm.4c01743.","journal-title":"ACS Appl Bio Mater"},{"key":"3846_CR45","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cca.2014.10.005","volume":"439","author":"R Chandirasekar","year":"2014","unstructured":"Chandirasekar R, Kumar BL, Jayakumar R, Uthayakumar V, Jacob R, Sasikala K. Evaluation of clinical and cytogenetic parameters in rheumatoid arthritis patients for effective diagnosis. Clin Chim Acta. 2014;439:77\u201383. https:\/\/doi.org\/10.1016\/j.cca.2014.10.005.","journal-title":"Clin Chim Acta"},{"key":"3846_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2020.551911","volume":"11","author":"KR Vijayarani","year":"2020","unstructured":"Vijayarani KR, Govindarajulu M, Ramesh S, Alturki M, Majrashi M, Fujihashi A, Almaghrabi M, Kirubakaran N, Ren J, Babu RJ, Smith F, Moore T, Dhanasekaran M. Enhanced bioavailability of Boswellic acid by Piper longum: A computational and Pharmacokinetic study. Front Pharmacol. 2020;11:1\u20138. https:\/\/doi.org\/10.3389\/fphar.2020.551911.","journal-title":"Front Pharmacol"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03846-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03846-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03846-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T06:36:58Z","timestamp":1763620618000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03846-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3846"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03846-5","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"725"}}